Published Technical Disclosure Archive

AI-Enhanced Cardiac Mapping and Ablation System

Publication ID: 24-11857251_0010_PTD
Published: November 07, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “AI-Enhanced Cardiac Mapping and Ablation System,” Published Technical Disclosure No. 24-11857251_0010_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857251_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,251.

Summary of the Inventive Concept

An advanced cardiac mapping and ablation system integrating AI-powered signal processing, cloud-based data analytics, and novel catheter designs for optimized personalized treatment planning and minimally invasive procedures.

Background and Problem Solved

The original patent's flexible circuit for use with a catheter and related manufacturing method has limitations in terms of real-time data analysis, personalized treatment planning, and minimally invasive procedures. The new inventive concept addresses these limitations by incorporating AI-powered signal processing, cloud-based data analytics, and advanced catheter designs to provide real-time cardiac mapping, optimized ablation therapy, and personalized treatment planning.

Detailed Description of the Inventive Concept

The AI-enhanced cardiac mapping and ablation system comprises a flexible circuit for a catheter tip with integrated AI-powered signal processing, a cloud-based data analytics platform, and novel catheter designs incorporating shape-memory alloy components, micro-electro-mechanical systems (MEMS), and integrated ultrasound transducers. The system enables real-time cardiac mapping, optimized ablation therapy, and personalized treatment planning through machine learning algorithms and cloud-based data analytics. The novel catheter designs provide enhanced maneuverability and real-time visualization during minimally invasive procedures.

Novelty and Inventive Step

The new inventive concept's integration of AI-powered signal processing, cloud-based data analytics, and advanced catheter designs provides a significant departure from the original patent's flexible circuit design. The use of machine learning algorithms, generative adversarial networks, and real-time feedback loops to optimize ablation therapy and personalize treatment planning represents a substantial inventive step.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different AI algorithms, alternative catheter designs, or the integration of additional sensors or imaging modalities. Variations of the system could be tailored to specific cardiac arrhythmias or patient populations, further expanding the scope of the inventive concept.

Potential Commercial Applications and Market

The AI-enhanced cardiac mapping and ablation system has significant commercial potential in the electrophysiology and cardiac ablation markets, with potential applications in hospitals, clinics, and research institutions. The system's ability to provide personalized treatment planning and optimized ablation therapy could lead to improved patient outcomes, reduced healthcare costs, and increased market share for companies adopting this technology.

CPC Classifications

SectionClassGroup
A A61 A61B18/1492
A A61 A61B5/287
A A61 A61B5/367
A A61 A61B8/4494
A A61 A61B2018/00351
A A61 A61B2018/00577

Field of Art

Medical device engineering, specifically cardiac mapping and ablation technologies, involving interdisciplinary expertise in electrical engineering, biomedical engineering, signal processing, and minimally invasive medical device design

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with advanced degrees, expertise in flexible circuit design, signal processing algorithms, medical device miniaturization, and familiarity with catheter-based diagnostic and therapeutic technologies

Obviousness Rationale

A PHOSITA would recognize that integrating AI-powered signal processing and advanced sensor technologies into existing flexible circuit catheter designs represents a predictable evolution of medical device innovation. The source patent's fundamental flexible circuit design provides a clear technological foundation for incorporating emerging computational and sensing technologies. The proposed variations represent logical extensions of known medical device engineering principles, applying state-of-the-art computational techniques to enhance existing diagnostic and therapeutic approaches.

Obvious Combinations & Variations

Source Patent Element
Flexible circuit design for catheter tip with electrode regions
PTD Variation
Integration of MEMS and AI-powered signal processing capabilities into flexible circuit
Obviousness Reasoning
Miniaturization and computational enhancement of medical devices is a well-established design progression, representing a predictable application of known technological improvements
Source Patent Element
Electrode configurations for cardiac mapping and ablation
PTD Variation
Real-time feedback loops and machine learning algorithms for dynamic energy delivery
Obviousness Reasoning
Adaptive control systems are standard engineering practice, and applying computational intelligence to medical device performance represents an obvious technological enhancement
Source Patent Element
Catheter tip flexible circuit design
PTD Variation
Shape-memory alloy components and integrated ultrasound transducers
Obviousness Reasoning
Material science and sensor integration are routine design strategies for improving medical device functionality, representing a predictable technological evolution
Source Patent Element
Cardiac mapping electrode configurations
PTD Variation
Cloud-based data analytics and generative adversarial network training approaches
Obviousness Reasoning
Computational data processing and machine learning techniques are standard approaches for enhancing medical diagnostic technologies
Source Patent Element
Electrophysiology catheter flexible circuit design
PTD Variation
AI-powered personalized treatment planning algorithms
Obviousness Reasoning
Personalization of medical interventions through computational analysis represents a logical and predictable technological progression in medical device engineering
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857251 and the disclosed technological variations, a person having ordinary skill in the art would find the proposed AI-enhanced cardiac mapping and ablation system technologies obvious and non-patentable, as they represent predictable extensions of existing flexible circuit and medical device design principles through standard engineering methodologies.

Original Patent Information

Patent NumberUS 11,857,251
TitleFlexible circuit for use with a catheter and related manufacturing method
Assignee(s)Biosense Webster (Israel) Ltd.